Blog

Peptides, explained
without the noise.

What each compound actually is, how it was dosed in the research, and what the data shows. No recommendations — just organised information.

Regulation

What Happens After the PCAC Vote

A recommendation is the first of four stages, and the other three have no deadline. What has to happen before a pharmacy may compound any of these peptides.

5 min read

Regulation

Why Emideltide Was the One Rejected

Six peptides went to the committee and came back recommended. The seventh did not. What separated it is more informative than the vote itself.

5 min read

Regulation

Is Compounded Tirzepatide Still Legal?

Tirzepatide moved before semaglutide, on a clause most summaries drop. The dates, the litigation still running, and why one date is later than usually quoted.

5 min read

General

What Peptide Cycling Is Based On

Eight weeks on, four off. The advice is everywhere and the derivation is nowhere. Where the idea actually came from, and what the approved drugs do instead.

5 min read

General

How Long Do Reconstituted Peptides Last?

An approved product has an in-use period because somebody ran the stability study. For most peptides nobody did, and the numbers online come from elsewhere.

5 min read

General

Subcutaneous or Intramuscular?

The route on a label is not a suggestion about comfort. It is the route the pharmacokinetics were measured in, and changing it changes what the dose data means.

5 min read

Regulation

Is Tesamorelin FDA Approved?

Yes in the United States, for one narrow indication almost nobody quotes. No in the EU, where the application was withdrawn in 2012. The distinction matters.

5 min read

Regulation

Are Peptides Legal in the EU and Bulgaria?

EU law requires a marketing authorisation before a medicinal product is placed on the market. What that means for unapproved peptides, and for Bulgaria.

5 min read

Regulation

Is Compounded Semaglutide Still Legal?

The shortage ended in February 2025 and the grace periods closed that spring. What the FDA position actually permits now, and the rule almost nobody quotes.

5 min read

Regulation

What the July 2026 FDA Peptide Vote Did

Six peptides recommended, one rejected, and nothing legal to compound yet. The tallies, the April reclassification behind it, and what still has to happen.

5 min read

Regulation

Which Peptides Are Actually Approved?

A status table for every compound on this site: approved as a medicine or not, whether US pharmacies may compound it, and where the anti-doping rules land.

5 min read

Epitalon

Is Epitalon Approved? Where the Evidence Ends

Epitalon holds no marketing authorisation and has no completed human trial. What the telomerase studies actually tested, and why the evidence base is so narrow.

4 min read

KPV

Is KPV Approved Anywhere? What the Data Say

KPV holds no marketing authorisation in any jurisdiction and every study behind it is preclinical. What the murine colitis work shows, and why the gut.

4 min read

MOTS-c

Is MOTS-c Approved? What the Evidence Shows

MOTS-c has no marketing authorisation anywhere and its human data are observational. What the 2015 discovery paper found about mitochondrial DNA and AMPK.

4 min read

General

Running a Peptide Protocol: The Parts

A protocol is five separate problems people treat as one: evidence, frequency, concentration, stability and site. A map of each, and where they connect.

4 min read

Semax

Is Semax Approved? Russia Yes, EU and US No

Semax is a registered medicine in Russia and unapproved everywhere else — neither the EMA nor the FDA has assessed it. What the research actually shows.

4 min read

TB-500

Is TB-500 Banned? WADA and FDA Status

TB-500 is prohibited in sport at all times and approved as a medicine nowhere. It is also not thymosin beta-4 — analysis found a short synthetic fragment.

5 min read

BPC-157

Is BPC-157 Legal? FDA and WADA Status

BPC-157 is approved as a medicine nowhere and banned in sport at all times. What the July 2026 FDA advisory vote changed, and what it did not.

4 min read

General

Injection Site Rotation and Lipohypertrophy

What lipohypertrophy is, why injection guidance insists on rotating sites, and what the FITTER recommendations say about spacing, needle reuse and inspection.

4 min read

General

Peptide Half-Life: Why Schedules Differ

Why some peptides are injected daily and others weekly — DPP-4 degradation, albumin binding, and what half-life means for steady state and a missed dose.

5 min read

General

Reconstitution and Concentration: The Arithmetic

What reconstitution does to a lyophilised peptide, why concentration is the only number that matters, and how mg, ml and syringe units relate to each other.

4 min read

Semaglutide

Semaglutide: What It Is and How It Works

What semaglutide is, how it acts on the GLP-1 receptor, and what the STEP and SELECT trials found about body weight and cardiovascular outcomes.

4 min read

General

Peptide Storage: What Actually Degrades Them

Why peptides are fragile molecules, what breaks them down — heat, light, freeze-thaw cycles and agitation — and what the official labelling says.

3 min read

Tirzepatide

Tirzepatide: What It Is and How It Works

What tirzepatide is, how it activates the GIP and GLP-1 receptors at the same time, and what the SURPASS and SURMOUNT trials actually found.

3 min read